1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    





































































































































    Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleAdult Brain

  
      
Open Access

  
      
Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden
  
    	
G.C. Chiang, J. Hu, E. Morris, Y. Wang and S.A. Gauthier

  
    	
American Journal of Neuroradiology March 2018,  39 (3) 467-472; DOI: https://doi.org/10.3174/ajnr.A5537 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. 

    2. Khalil  M, 
    3. Langkammer  C, 
    4. Pichler  A, et al
    . Dynamics of brain iron levels in multiple sclerosis: a longitudinal 3T MRI study. Neurology 2015;84:2396–402 doi:10.1212/WNL.0000000000001679 pmid:25979698
    CrossRefPubMed
  2. 2.↵
    1. 

    2. Cifelli  A, 
    3. Arridge  M, 
    4. Jezzard  P, et al
    . Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650–53 doi:10.1002/ana.10326 pmid:12402265
    CrossRefPubMedWeb of Science
  3. 3.↵
    1. 

    2. Hagemeier  J, 
    3. Yeh  EA, 
    4. Brown  MH, et al
    . Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Mult Scler 2013;19:567–76 doi:10.1177/1352458512459289 pmid:22968543
    CrossRefPubMed
  4. 4.↵
    1. 

    2. Zivadinov  R, 
    3. Heininen-Brown  M, 
    4. Schirda  CV, et al
    . Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 2012;59:331–39 doi:10.1016/j.neuroimage.2011.07.045 pmid:21820063
    CrossRefPubMedWeb of Science
  5. 5.↵
    1. 

    2. Bergsland  N, 
    3. Zivadinov  R, 
    4. Dwyer  MG, et al
    . Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Mult Scler 2016;22:1327–36 doi:10.1177/1352458515616204 pmid:26541795
    CrossRefPubMed
  6. 6.↵
    1. 

    2. Schoonheim  MM, 
    3. Hulst  HE, 
    4. Brandt  RB, et al
    . Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology 2015;84:776–83 doi:10.1212/WNL.0000000000001285 pmid:25616483
    CrossRefPubMed
  7. 7.↵
    1. 

    2. Ramasamy  DP, 
    3. Benedict  RH, 
    4. Cox  JL, et al
    . Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. J Neurol Sci 2009;282:47–54 doi:10.1016/j.jns.2008.12.034 pmid:19201003
    CrossRefPubMedWeb of Science
  8. 8.↵
    1. 

    2. Mosca  TJ, 
    3. Hong  W, 
    4. Dani  VS, et al
    . Trans-synaptic Teneurin signalling in neuromuscular synapse or organization and target choice. Nature 2012;484:237–41 doi:10.1038/nature10923 pmid:22426000
    CrossRefPubMedWeb of Science
  9. 9.↵
    1. 

    2. Nikoletopoulou  V, 
    3. Lickert  H, 
    4. Frade  JM, et al
    . Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 2010;467:59–63 doi:10.1038/nature09336 pmid:20811452
    CrossRefPubMedWeb of Science
  10. 10.↵
    1. 

    2. Rocca  MA, 
    3. Mesaros  S, 
    4. Pagani  E, et al
    . Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology 2010;257:463–69 doi:10.1148/radiol.10100326 pmid:20724544
    CrossRefPubMedWeb of Science
  11. 11.↵
    1. 

    2. Deppe  M, 
    3. Krämer  J, 
    4. Tenberge  JG, et al
    . Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis. Hum Brain Mapp 2016;37:1866–79 doi:10.1002/hbm.23144 pmid:26920497
    CrossRefPubMed
  12. 12.↵
    1. 

    2. Modica  CM, 
    3. Zivadinov  R, 
    4. Dwyer  MG, et al
    . Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis. AJNR Am J Neuroradiol 2015;36:57–62 doi:10.3174/ajnr.A3998 pmid:24948507
    Abstract/FREE Full Text
  13. 13.↵
    1. 

    2. Al-Radaideh  AM, 
    3. Wharton  SJ, 
    4. Lim  SY, et al
    . Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome. Mult Scler 2013;19:896–903 doi:10.1177/1352458512465135 pmid:23139386
    CrossRefPubMed
  14. 14.↵
    1. 

    2. Hagemeier  J, 
    3. Weinstock-Guttman  B, 
    4. Bergland  N, et al
    . Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 2012;33:1596–601 doi:10.3174/ajnr.A3030 pmid:22460343
    Abstract/FREE Full Text
  15. 15.↵
    1. 

    2. Cobzas  D, 
    3. Sun  H, 
    4. Walsh  AJ, et al
    . Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis. J Magn Reson Imaging 2015;42:1601–10 doi:10.1002/jmri.24951 pmid:25980643
    CrossRefPubMed
  16. 16.↵
    1. 

    2. Ge  Y, 
    3. Jensen  JH, 
    4. Lu  H, et al
    . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639–44 doi:10.3174/ajnr.A0646 pmid:17893225
    Abstract/FREE Full Text
  17. 17.↵
    1. 

    2. Lebel  RM, 
    3. Eissa  A, 
    4. Seres  P, et al
    . Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult Scler 2012;18:433–41 doi:10.1177/1352458511428464 pmid:22032862
    CrossRefPubMed
  18. 18.↵
    1. 

    2. Quinn  MP, 
    3. Gati  JS, 
    4. Klassen  ML, et al
    . Increased deep gray matter iron is present in clinically isolated syndromes. Mult Scler Relat Disord 2014;3:194–202 doi:10.1016/j.msard.2013.06.017 pmid:25878007
    CrossRefPubMed
  19. 19.↵
    1. 

    2. Khalil  M, 
    3. Langkammer  C, 
    4. Ropele  S, et al
    . Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77:1691–97 doi:10.1212/WNL.0b013e318236ef0e pmid:21975210
    Abstract/FREE Full Text
  20. 20.↵
    1. 

    2. Kwan  JY, 
    3. Jeong  SY, 
    4. Van Gelderen  P, et al
    . Iron accumulation in deep cortical layers account for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS One 2012;7:e35241 doi:10.1371/journal.pone.0035241 pmid:22529995
    CrossRefPubMed
  21. 21.↵
    1. 

    2. Zecca  L, 
    3. Youdim  MB, 
    4. Riederer  P, et al
    . Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863–73 doi:10.1038/nrn1537 pmid:15496864
    CrossRefPubMedWeb of Science
  22. 22.↵
    1. 

    2. Haider  L, 
    3. Simeonidou  C, 
    4. Steinberger  G, et al
    . Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry 2014;85:1386–95 doi:10.1136/jnnp-2014-307712 pmid:24899728
    Abstract/FREE Full Text
  23. 23.↵
    1. 

    2. Garden  GA, 
    3. Möller  T
    . Microglia biology in health and disease. J Neuroimmune Pharmacol 2006;1:127–37 doi:10.1007/s11481-006-9015-5 pmid:18040779
    CrossRefPubMed
  24. 24.↵
    1. 

    2. Cheepsunthorn  P, 
    3. Radov  L, 
    4. Menzies  S, et al
    . Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 2001;35:53–62 doi:10.1002/glia.1070 pmid:11424192
    CrossRefPubMedWeb of Science
  25. 25.↵
    1. 

    2. Andersen  HH, 
    3. Johnsen  KB, 
    4. Moos  T
    . Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell Mol Life Sci 2014;71:1607–22 doi:10.1007/s00018-013-1509-8 pmid:24218010
    CrossRefPubMed
  26. 26.↵
    1. 

    2. Walsh  AJ, 
    3. Blevins  G, 
    4. Lebel  RM, et al
    . Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology 2014;270:186–96 doi:10.1148/radiol.13130474 pmid:23925273
    CrossRefPubMed
  27. 27.↵
    1. 

    2. Langkammer  C, 
    3. Schweser  F, 
    4. Krebs  N, et al
    . Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012;62:1593–99 doi:10.1016/j.neuroimage.2012.05.049 pmid:22634862
    CrossRefPubMed
  28. 28.↵
    1. 

    2. Liu  J, 
    3. Liu  T, 
    4. de Rochefort  L, et al
    . Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59:2560–68 doi:10.1016/j.neuroimage.2011.08.082 pmid:21925276
    CrossRefPubMed
  29. 29.↵
    1. 

    2. Fischl  B, 
    3. Salat  DH, 
    4. Busa  E, et al
    . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55 doi:10.1016/S0896-6273(02)00569-X pmid:11832223
    CrossRefPubMedWeb of Science
  30. 30.↵
    1. 

    2. Mukaka  MM
    . Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 2012;24:69–71 pmid:23638278
    PubMedWeb of Science
  31. 31.↵
    1. 

    2. Wisnieff  C, 
    3. Ramanan  S, 
    4. Olesik  J, et al
    . Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron. Magn Reson Med 2015;74:564–70 doi:10.1002/mrm.25420 pmid:25137340
    CrossRefPubMed
  32. 32.↵
    1. 

    2. Sun  H, 
    3. Walsh  AJ, 
    4. Lebel  RM, et al
    . Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter. Neuroimage 2015;105:486–92 doi:10.1016/j.neuroimage.2014.11.010 pmid:25462797
    CrossRefPubMed
  33. 33.↵
    1. 

    2. Schmalbrock  P, 
    3. Prakash  RS, 
    4. Schirda  B, et al
    . Basal ganglia iron in patients with multiple sclerosis measured with 7T quantitative susceptibility mapping correlates with inhibitory control. AJNR Am J Neuroradiol 2016;37:439–46 doi:10.3174/ajnr.A4599 pmid:26611996
    Abstract/FREE Full Text
  34. 34.↵
    1. 

    2. Wang  Y, 
    3. Liu  T
    . Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 2015;73:82–101 doi:10.1002/mrm.25358 pmid:25044035
    CrossRefPubMed
  35. 35.↵
    1. 

    2. Schweser  F, 
    3. Deistung  A, 
    4. Lehr  BW, et al
    . Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med Phys 2010;37:5165–78 doi:10.1118/1.3481505 pmid:21089750
    CrossRefPubMed
  36. 36.↵
    1. 

    2. Haacke  EM, 
    3. Miao  Y, 
    4. Liu  M, et al
    . Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J Magn Reson Imaging 2010;32:561–76 doi:10.1002/jmri.22293 pmid:20815053
    CrossRefPubMed
  37. 37.↵
    1. 

    2. Barbeito  AG, 
    3. Garringer  HJ, 
    4. Baraibar  MA, et al
    . Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem 2009;109:1067–78 doi:10.1111/j.1471-4159.2009.06028.x pmid:19519778
    CrossRefPubMed
  38. 38.↵
    1. 

    2. Deng  X, 
    3. Vidal  R, 
    4. Englander  EW
    . Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy. Neurosci Lett 2010;479:44–48 doi:10.1016/j.neulet.2010.05.025 pmid:20478358
    CrossRefPubMed
  39. 39.↵
    1. 

    2. Pelizzoni  I, 
    3. Macco  R, 
    4. Morini  MF, et al
    . Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell 2011;10:172–83 doi:10.1111/j.1474-9726.2010.00652.x pmid:21108725
    CrossRefPubMedWeb of Science
  40. 40.↵
    1. 

    2. Rogers  JT, 
    3. Bridges  KR, 
    4. Durmowicz  GP, et al
    . Translational control during the acute phase response: ferritin synthesis in response to interleukin-1. J Biol Chem 1990;265:14572–78 pmid:1696948
    Abstract/FREE Full Text
  41. 41.↵
    1. 

    2. Tsuji  Y, 
    3. Miller  LL, 
    4. Miller  SC, et al
    . Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem 1991;266:7257–61 pmid:2016326
    Abstract/FREE Full Text
  42. 42.↵
    1. 

    2. Smirnov  IM, 
    3. Bailey  K, 
    4. Flowers  CH, et al
    . Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity. Am J Physiol 1999;277:L257–63 pmid:10444519
    PubMed
  43. 43.↵
    1. 

    2. Williams  R, 
    3. Rohr  AM, 
    4. Wang  WT, et al
    . Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci 2011;12:59 doi:10.1186/1471-2202-12-59 pmid:21699685
    CrossRefPubMed
  44. 44.↵
    1. 

    2. Shoham  S, 
    3. Werman  E, 
    4. Ebstein  RP
    . Iron accumulation in the rat basal ganglia after excitatory amino acid injections: dissociation from neuronal loss. Exp Neurol 1992;118:227–41 doi:10.1016/0014-4886(92)90039-S pmid:1426129
    CrossRefPubMed
  45. 45.↵
    1. 

    2. Sastry  S, 
    3. Arendash  GW
    . Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex. Neuroscience 1995;67:649–66 doi:10.1016/0306-4522(94)00618-F pmid:7545796
    CrossRefPubMedWeb of Science
  46. 46.↵
    1. 

    2. Radlinska  BA, 
    3. Ghinani  SA, 
    4. Lyon  P, et al
    . Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann Neurol 2009;66:825–32 doi:10.1002/ana.21796 pmid:20035510
    CrossRefPubMed
  47. 47.↵
    1. 

    2. Aquino  D, 
    3. Bizzi  A, 
    4. Grisoli  M, et al
    . Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009;252:165–72 doi:10.1148/radiol.2522081399 pmid:19561255
    CrossRefPubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden
  
    	
G.C. Chiang, J. Hu, E. Morris, Y. Wang, S.A. Gauthier

  
    	
 American Journal of Neuroradiology Mar 2018, 39 (3) 467-472; DOI: 10.3174/ajnr.A5537 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement